← All candidates
One insider buy in the last year — $118.3K in all.
60 filings on record.
NUVBNuvation Bio Inc.
NYSE · Healthcare · $2.04B
$5.80
-2.36% · Sep 15
One insider buy in the last year — $118.3K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 1 buy● 14 sells◆ 5 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$2.04B
Float
263.6M
75% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
12.0
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
PRESIDENT AND CEO
Hung David
Bought $893.5K on Jun 16 — 500,000 sh @ $1.79, held direct, 0.8% of their stake.
1 of 1 position beat the S&P
Director
Mashal Robert
Bought $118.3K on Jun 9 — 25,000 sh @ $4.73, held indirect, 11% of their stake.
First Form 4 on file
Chief Commercial Officer
Sjogren Colleen
Bought $90.3K on Jun 16 — 50,000 sh @ $1.81, held direct, 62% of their stake.
1 of 1 position beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
25 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
33 more transactions on Pro →Context
Wall St
$12.33 avg target
+112.6% vs today · 9 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q1 '26$0.04 act−$0.01
Q4 '25−$0.09 act−$0.04
Q3 '25−$0.14 act+$0.01
Q2 '25−$0.14 act+$0.00
Coverage
Here’s What the Acquisition of Nuvalent Means for Nuvation Bio (NUVB)Insider Monkey · 06-16Nuvation Bio Sharpens IBTROZI Focus With Thermo Fisher And FDA StepsSimply Wall St. · 05-18Is Nuvation Bio (NUVB) the Best Penny Stock to Buy Before It Explodes?Insider Monkey · 05-13Nuvation Bio Inc. Beat Analyst Profit Forecasts, And Analysts Have New EstimatesSimply Wall St. · 05-08
The file stays open
60 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice